Skip to main content

Health condition

Alpha-1 antitrypsin liver disease

Alpha-1 antitrypsin deficiency can affect the liver as well as the lungs: abnormal protein accumulates in liver cells and can cause scarring at any age.

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against current NHS and UK specialist society guidance at the time of review.

  • 03

    Current for 2026

    Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.

Key facts

The essentials at a glance.

The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.

  • Suspect it in unexplained liver disease, especially with emphysema in the family or at a young age

  • Diagnosis: a blood level plus genotype or phenotype testing

  • Specialist: a consultant hepatologist, usually alongside a respiratory physician

  • Management includes avoiding alcohol excess and smoking, monitoring with FibroScan, and transplantation for advanced disease

Understanding the condition

What it is and what happens next.

What causes it, how it is diagnosed, and the treatment routes available in the UK.

What it is and how it feels

Alpha-1 antitrypsin is made in the liver, and in people carrying the abnormal Z variant the misfolded protein is retained inside liver cells rather than released. In some carriers this triggers inflammation and progressive fibrosis, in childhood or, more often, in mid-life, quite separately from the lung disease the deficiency causes.

Diagnosis and treatment routes

A simple blood test measuring the alpha-1 antitrypsin level, followed by genotyping, secures the diagnosis, and a FibroScan stages any scarring. There is no specific drug for the liver component yet, so care focuses on protecting the liver, weight, alcohol, vaccination, regular monitoring, with liver transplantation curative for the minority who progress to cirrhosis. In many parts of the UK, routine NHS referrals for this kind of problem currently take 20-45+ weeks, whereas an initial appointment with a private consultant is typically available within around two weeks.

Seeing a specialist

Who to see, and how quickly you can be seen.

The specialist for this condition is usually a consultant hepatologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.

Frequently asked

Common questions about Alpha-1 antitrypsin liver disease.

Quick, plain-English answers to what people ask us most.

  • What is alpha-1 antitrypsin liver disease?

    Alpha-1 antitrypsin liver disease is liver damage caused by an inherited deficiency in alpha-1 antitrypsin, where an abnormal form of the protein accumulates within liver cells and causes progressive injury.

  • What causes alpha-1 antitrypsin liver disease?

    It is caused by specific genetic variants, particularly the Z allele, which produce a misfolded protein that gets trapped in liver cells rather than being released into the bloodstream, causing cellular damage over time.

  • What are the symptoms of alpha-1 antitrypsin liver disease?

    Symptoms can range from none at all in mild cases to jaundice, fatigue, and abdominal swelling, with more advanced disease showing signs of cirrhosis such as easy bruising or fluid retention.

  • Is alpha-1 antitrypsin liver disease dangerous?

    Yes, it can progress to cirrhosis, liver failure, and increases long-term risk of liver cancer in a proportion of affected individuals, making regular specialist monitoring valuable.

  • Is alpha-1 antitrypsin liver disease genetic?

    Yes, it is an inherited condition, with the severity of liver involvement varying depending on the specific combination of gene variants a person carries.

  • Can alpha-1 antitrypsin liver disease be treated?

    There is no medication that directly reverses the liver protein build-up, but avoiding alcohol, monitoring for complications, and managing any cirrhosis-related issues can help, with liver transplant available for advanced disease.

  • How is alpha-1 antitrypsin liver disease monitored?

    Regular liver blood tests, periodic imaging, and cancer surveillance in higher-risk patients with cirrhosis are typically part of ongoing monitoring for this condition.

  • Alpha-1 antitrypsin liver disease vs other causes of cirrhosis — what's the difference?

    Unlike cirrhosis from causes such as alcohol or viral hepatitis, alpha-1 antitrypsin liver disease has a specific inherited genetic cause, confirmed through blood testing and genotyping, which also has implications for family members who may wish to be tested.

  • Does everyone with alpha-1 antitrypsin deficiency develop liver disease?

    No, not everyone develops significant liver disease; risk depends on the specific genetic variant combination, with some people having minimal or no liver involvement despite carrying deficiency-associated gene variants.

  • When should I see a doctor about possible alpha-1 antitrypsin liver disease, and how quickly can I be seen privately?

    See a doctor if you have unexplained liver problems or a relevant family history. NHS hepatology referral can take several weeks, while private specialist assessment is often available within about two weeks.